[{"id":"53ffeb2e-2025-434c-8ac8-ee1e44968dd2","acronym":"","url":"https://clinicaltrials.gov/study/NCT05325281","created_at":"2022-04-16T16:18:13.640Z","updated_at":"2025-02-25T16:32:58.264Z","phase":"Phase 1","brief_title":"CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma","source_id_and_acronym":"NCT05325281","lead_sponsor":"Medical College of Wisconsin","biomarkers":" CEACAM5","pipe":"","alterations":" ","tags":["CEACAM5"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e gemcitabine • Bylantra (devimistat)"],"overall_status":"Recruiting","enrollment":" Enrollment 24","initiation":"Initiation: 10/31/2022","start_date":" 10/31/2022","primary_txt":" Primary completion: 08/01/2025","primary_completion_date":" 08/01/2025","study_txt":" Completion: 08/01/2027","study_completion_date":" 08/01/2027","last_update_posted":"2024-07-29"},{"id":"5d576388-a550-4b35-b698-5134873cd7dd","acronym":"","url":"https://clinicaltrials.gov/study/NCT03793140","created_at":"2021-01-18T18:45:13.009Z","updated_at":"2024-07-02T16:35:08.385Z","phase":"Phase 2","brief_title":"A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations","source_id_and_acronym":"NCT03793140","lead_sponsor":"Memorial Sloan Kettering Cancer Center","biomarkers":" MYC • BCL2 • BCL6","pipe":" | ","alterations":" MYC rearrangement","tags":["MYC • BCL2 • BCL6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MYC rearrangement"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Bylantra (devimistat)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 24","initiation":"Initiation: 12/31/2018","start_date":" 12/31/2018","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2024-04-22"},{"id":"ce857425-f1aa-4d42-9b1c-d8e65b7aa9f8","acronym":"","url":"https://clinicaltrials.gov/study/NCT02232152","created_at":"2021-01-18T10:28:21.072Z","updated_at":"2024-07-02T16:35:40.756Z","phase":"Phase 1","brief_title":"CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery","source_id_and_acronym":"NCT02232152","lead_sponsor":"Wake Forest University Health Sciences","biomarkers":" KRAS","pipe":" | ","alterations":" KRAS wild-type • RAS wild-type","tags":["KRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRAS wild-type • RAS wild-type"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e 5-fluorouracil • Bylantra (devimistat)"],"overall_status":"Completed","enrollment":" Enrollment 19","initiation":"Initiation: 01/06/2015","start_date":" 01/06/2015","primary_txt":" Primary completion: 02/19/2019","primary_completion_date":" 02/19/2019","study_txt":" Completion: 01/11/2023","study_completion_date":" 01/11/2023","last_update_posted":"2023-08-07"}]